| Target Price | €27.80 |
| Price | €17.86 |
| Potential |
55.63%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target M1 Kliniken 2026 .
The average M1 Kliniken target price is €27.80.
This is
55.63%
register free of charge
€29.40
64.61%
register free of charge
€23.74
32.89%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend M1 Kliniken to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the M1 Kliniken stock has an average upside potential 2026 of
55.63%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million € | 339.18 | 365.47 |
| 7.23% | 7.75% | |
| EBITDA Margin | 9.33% | 9.38% |
| 48.98% | 0.59% | |
| Net Margin | 4.72% | 4.76% |
| 45.48% | 0.78% |
5 Analysts have issued a sales forecast M1 Kliniken 2025 . The average M1 Kliniken sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an M1 Kliniken EBITDA forecast 2025. The average M1 Kliniken EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 M1 Kliniken Analysts have issued a net profit forecast 2025. The average M1 Kliniken net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.82 | 0.93 |
| 57.69% | 13.41% | |
| P/E | 19.28 | |
| EV/Sales | 0.84 |
5 Analysts have issued a M1 Kliniken forecast for earnings per share. The average M1 Kliniken EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Dec 03 2025 |
| METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Nov 28 2025 |
| METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Sep 15 2025 |
| FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Sep 03 2025 |
| FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jul 09 2025 |
| FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jul 08 2025 |
| WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | Jun 30 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Dec 03 2025 |
|
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Nov 28 2025 |
|
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Sep 15 2025 |
|
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Sep 03 2025 |
|
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Jul 09 2025 |
|
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Jul 08 2025 |
|
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
Jun 30 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


